Status:
UNKNOWN
Data Collection of Normal Tissue Toxicity for Proton Therapy for Pediatrics
Lead Sponsor:
M.D. Anderson Cancer Center
Conditions:
Pediatric Cancer
Eligibility:
All Genders
Up to 18 years
Brief Summary
The goal of this research study is to collect information on the side effects of proton therapy and the details of proton treatment plans so that researchers can develop a method to predict the risk o...
Detailed Description
If you agree to take part in this study, researchers will gather information about your treatment and treatment outcomes and store it electronically in a database. By carefully evaluating the data abo...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- All patients under the age of 18 who are treated with PBT will be eligible to participate in this trial.
- Signed informed consent must be obtained from the patient or patient's representative prior to study enrollment.
- Exclusion Criteria:
- Pregnant females are not eligible.
- Patient or patient's parent or legal guardian representative is unable or unwilling to give informed consent.
Exclusion
Key Trial Info
Start Date :
June 16 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2021
Estimated Enrollment :
798 Patients enrolled
Trial Details
Trial ID
NCT01502150
Start Date
June 16 2005
End Date
June 1 2021
Last Update
May 10 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Texas MD Anderson Cancer Center
Houston, Texas, United States, 77030